Reagents, Calibrators and Controls, Solutions, and Consumables for Coagulation Analyzers ACL Top 350
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Indian Health Service (IHS), specifically the Kayenta Health Center (KHC), is soliciting proposals for reagents, calibrators, controls, solutions, and consumables for their Werfen's ACL Top 350 CTS coagulation analyzers. This requirement supports critical direct acute patient care at the Kayenta, AZ facility. Offers are due by March 16, 2026, at 5:00 PM MST.
Scope of Work
The requirement is for specific supplies compatible with the Werfen's ACL Top 350 CTS system. Key deliverables include:
- HemosIL RecombiPlasTin 2G, SynthASil, Q.F.A Thrombin, D-Dimer HS 500
- HemosIL Normal Control 1, Abnormal Control 3, Calibration plasma, D-Dimer HS 500 Controls, Low Fibrinogen Control
- HemosIL Rinse solution 4L, Cleaning Agent (Clean B), Factor Diluent, Cleaning Solution (Clean A)
- Waste containers (10 pack), CTS filters, and ACL Top cuvettes (6x100x4). Anticipated delivery is 30 days After Receipt of Order (ARO).
Contract & Timeline
- Type: Solicitation for Commercial Items (Simplified Procedures)
- Period of Performance: April 1, 2026, to March 31, 2027
- Set-Aside: Unrestricted
- NAICS Code: 334516 (Size Standard: 1,000 employees)
- Offers Due: March 16, 2026, at 5:00 PM MST
- Published: March 2, 2026
Submission & Evaluation
Proposals must be submitted in PDF format and include specific volumes: Administrative Documents, Specifications and Delivery/Schedule, and Price. Failure to follow instructions may render quotes unacceptable. Award will be based on a Lowest Price Technically Acceptable (LPTA) evaluation. Technical capability will be assessed against Attachment A – Specification Sheet, with Delivery and Price also serving as evaluation factors.
Additional Notes
This acquisition includes a Brand Name Justification (Attachment B) indicating that only Werfen USA LLC is reasonably available due to the specialized requirements of the ACL Top 350 CTS system. The contract is subject to electronic payment processes via www.ipp.gov and incorporates various FAR and HHSAR clauses. Contact: Flora Washington, flora.washington@ihs.gov, 928-380-8345.